Objective To determine the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis (AS) population.

In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

HonorHealth Research Institute clinical trial, using non-surgical techniques, showed 86% of patients with a type of usually ...

A medical patient from Peterborough is among the first to receive a pioneering treatment for heart valve disease.

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

ABSTRACT. Introduction: The clinical significance of new-onset left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) remains controversial.In the presented study, we ...

The prevalence of aortic stenosis (AS) and amyloid transthyretin cardiomyopathy (ATTR‐CM) increases with age. While the global prevalence of calcific aortic valve disease is estimated to be >2% in ...

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 10,314,694 Comment Due Date 08/15/2025 Docket ID FDA-2023-E-3308 Supporting Documents No ...

In the initial PARTNER trial (Placement of Aortic Transcatheter Valves) of transcatheter aortic valve replacement for high-risk (HR) and inoperable patients, mortality at 1 year was 24% in HR and 31% ...

Objective To compare the clinical outcomes and haemodynamic performance following transcatheter aortic valve replacement (TAVR) in patients with severe bicuspid versus tricuspid aortic stenosis (AS) ...

Introduction. Decompensated aortic valvular stenosis is a condition characterised by high mortality if treated medically and a significantly increased risk of perioperative mortality and morbidity in ...